dsm-firmenich's Ongoing Share Repurchase Program Overview
dsm-firmenich, a leader in the nutrition, health, and beauty sectors, continues to make significant strides in its strategic share repurchase program. Announced earlier in 2025, the company set a target to repurchase ordinary shares valued at €1 billion, with an initial focus on a commitment of €500 million. This initiative aims not only to align with shareholder interests but also to strengthen its financial structure.
Recent Developments in the Share Repurchase Initiative
On April 1, 2025, dsm-firmenich initiated this substantial share repurchase program, allocating a majority of the first tranche totaling €580 million for repurchasing shares. A noteworthy aspect of this program includes €80 million designated for fulfilling obligations related to the Group’s share-based compensation plans, while the remaining €500 million serves the purpose of reducing the company’s issued capital.
Share Repurchase Figures and Pricing
Between April 14 and April 17, 2025, dsm-firmenich has reported the repurchase of a total of 153,322 shares. These purchases incurred an average cost of €88.91 per share, accumulating to a total expenditure of €13.6 million during this short window. Cumulatively, the total share count acquired under this program now stands at 502,991 shares, with the average price at €88.26, leading to an overall investment of €44.4 million.
Future Plans for Share Repurchases
The current share buyback program is scheduled to conclude within six months of its launch. Following the completion of the sale of dsm-firmenich's stake in the Feed Enzymes Alliance, the company intends to execute an additional €500 million toward further share repurchases. This signals the firm’s commitment to optimizing capital structure and enhancing shareholder value over the long haul.
Investor Relations and Company Contact Information
For those interested in more details regarding dsm-firmenich’s corporate initiatives and financial performance, the investor relations team is available for enquiries. Individuals may reach out via email at investors@dsm-firmenich.com. Additionally, the media inquiries can be directed to media@dsm-firmenich.com.
About dsm-firmenich
dsm-firmenich takes pride in being at the forefront of innovation within the nutrition, health, and beauty industries. Focused on delivering essential nutrients and unique sensory experiences, the company thrives on a commitment to sustainability and quality. Operating out of two primary headquarters in Kaiseraugst, Switzerland, and Maastricht, Netherlands, dsm-firmenich ranks high on the Euronext Amsterdam. With nearly 30,000 dedicated employees, the company generates impressive revenues exceeding €12 billion and caters to a growing global populace.
Frequently Asked Questions
What is the purpose of dsm-firmenich's share repurchase program?
The share repurchase program aims to enhance shareholder value and reduce issued capital while fulfilling obligations related to compensation plans.
How much total is allocated for the share repurchase program?
The total allocation for the repurchase program is €1 billion, starting with an initial amount of €580 million.
What are the recent share repurchase numbers reported?
As of mid-April 2025, dsm-firmenich repurchased 153,322 shares at an average price of €88.91 per share.
When is the current share repurchase program expected to conclude?
The current repurchase program is expected to be completed within six months from its initiation on April 1, 2025.
Who can be contacted for further investor inquiries?
Investors can reach out to the dsm-firmenich investor relations team at investors@dsm-firmenich.com.
